Actively Recruiting
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
Led by Andrea Goldmann · Updated on 2025-07-02
486
Participants Needed
15
Research Sites
126 weeks
Total Duration
On this page
Sponsors
A
Andrea Goldmann
Lead Sponsor
S
Spital Männedorf
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about the potential differences in morbidity of thyroidectomy (removal of the thyroid gland) depending on the preoperative hormonal status. The main question it aims to answer is: Do patients undergoing thyroidectomy for thyreotoxicosis (thyroid hyperfunction) due to Graves' disease or Amiodarone induced thyreotoxicosis have comparable complication rates depending on their thyroid metabolic status prior or during the procedure. The data from participants undergoing a thyroidectomy at one of the study sites will be prospectively registered in the EUROCRINE registry, including an add-on module for additional study specific routine data. The operation itself, the preoperative or postoperative treatments are not altered in any way.
CONDITIONS
Official Title
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 years or older undergoing thyroid surgery for Graves' disease or Amiodarone-induced thyrotoxicosis with confirmed hyperthyroidism or on specific medication for these conditions
- Patients who have signed informed consent to participate in the study
You will not qualify if you...
- Children and minors under 18 years of age
- Pregnant women
- Patients unable or unwilling to give informed consent due to language or intellectual difficulties
- Patients having additional parathyroid surgery, lymph node removal, or repeat thyroid surgery
- Patients undergoing thyroid surgery for reasons other than Graves' disease or Amiodarone-induced thyrotoxicosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
OLV Ziekenhuis
Aalst, Belgium
Actively Recruiting
2
Universite de Lorraine, Cru Nancy
Nancy, France
Actively Recruiting
3
Evgenidion Hospital Athens
Athens, Greece
Actively Recruiting
4
Universitario Virgen de las Nieves
Granada, Spain
Actively Recruiting
5
Hospital Costa del Sol
Marbella, Spain
Actively Recruiting
6
Kantonsspital Winterthur
Zurich, Winterthur, Switzerland, 8400
Actively Recruiting
7
Clarunis St. Clara Spital
Basel, Switzerland
Not Yet Recruiting
8
Universitätsspital Bern, Inselspital
Bern, Switzerland
Actively Recruiting
9
University Hospitals of Geneva
Geneva, Switzerland
Actively Recruiting
10
University Hospital of Lausanne CHUV
Lausanne, Switzerland
Actively Recruiting
11
Kantonsspital Basel Land
Liestal, Switzerland
Not Yet Recruiting
12
Spital Männedorf
Männedorf, Switzerland
Actively Recruiting
13
Ospedale Regionale di Mendrisio
Mendrisio, Switzerland
Actively Recruiting
14
HOCH Kantonsspital St. Gallen
Sankt Gallen, Switzerland
Actively Recruiting
15
Spital Limmattal
Schlieren, Switzerland
Actively Recruiting
Research Team
A
Andrea Goldmann, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here